Shen D - Search Results

1

[Nimotuzumab in combination with chemotherapy for patients with malignant gliomas].

Yang QY, Shen D, Sai K, Mu YG, Jiang XB, Zhang XH, Chen ZP. Yang QY, et al. Among authors: shen d. Zhonghua Zhong Liu Za Zhi. 2011 Mar;33(3):232-5. Zhonghua Zhong Liu Za Zhi. 2011. PMID: 21575527 Chinese.

2

[Survival of newly diagnosed malignant glioma patients on combined modality therapy].

Yang QY, Shen D, Sai K, Jiang XB, Ke C, Zhang XH, Mou YG, Chen ZP. Yang QY, et al. Among authors: shen d. Zhonghua Yi Xue Za Zhi. 2013 Jan 1;93(1):8-10. Zhonghua Yi Xue Za Zhi. 2013. PMID: 23578444 Chinese.

3

Chemotherapy for gliomas in mainland China: An overview.

Sai K, Yang QY, Shen D, Chen ZP. Sai K, et al. Among authors: shen d. Oncol Lett. 2013 May;5(5):1448-1452. doi: 10.3892/ol.2013.1264. Epub 2013 Mar 19. Oncol Lett. 2013. PMID: 23761809 Free PMC article.

4

Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells.

Qiu ZK, Shen D, Chen YS, Yang QY, Guo CC, Feng BH, Chen ZP. Qiu ZK, et al. Among authors: shen d. Chin J Cancer. 2014 Feb;33(2):115-22. doi: 10.5732/cjc.012.10236. Epub 2013 Aug 6. Chin J Cancer. 2014. PMID: 23958055 Free PMC article.

5

Interferon-α/β enhances temozolomide activity against MGMT-positive glioma stem-like cells.

Shen D, Guo CC, Wang J, Qiu ZK, Sai K, Yang QY, Chen YS, Chen FR, Wang J, Panasci L, Chen ZP. Shen D, et al. Oncol Rep. 2015 Nov;34(5):2715-21. doi: 10.3892/or.2015.4232. Epub 2015 Aug 27. Oncol Rep. 2015. PMID: 26329778

6

MGMT promoter methylation correlates with an overall survival benefit in Chinese high-grade glioblastoma patients treated with radiotherapy and alkylating agent-based chemotherapy: a single-institution study.

Shen D, Liu T, Lin Q, Lu X, Wang Q, Lin F, Mao W. Shen D, et al. PLoS One. 2014 Sep 11;9(9):e107558. doi: 10.1371/journal.pone.0107558. eCollection 2014. PLoS One. 2014. PMID: 25211033 Free PMC article.

7

A Pan-Cancer Study of KMT2 Family as Therapeutic Targets in Cancer.

Zhu J, Liu Z, Liang X, Wang L, Wu D, Mao W, Shen D. Zhu J, et al. Among authors: shen d. J Oncol. 2022 Jan 11;2022:3982226. doi: 10.1155/2022/3982226. eCollection 2022. J Oncol. 2022. PMID: 35058979 Free PMC article.

8

TAB3 promotes human esophageal squamous cell carcinoma proliferation and invasion via the NF‑κB pathway.

Zhao J, Gai L, Gao Y, Xia W, Shen D, Lin Q, Mao W, Wang F, Liu P, Chen J. Zhao J, et al. Among authors: shen d. Oncol Rep. 2018 Nov;40(5):2876-2885. doi: 10.3892/or.2018.6686. Epub 2018 Sep 6. Oncol Rep. 2018. PMID: 30226617

9

MicroRNA-181a inhibits tumor proliferation, invasiveness, and metastasis and is downregulated in gastric cancer.

Lin F, Li Y, Yan S, Liu S, Qian W, Shen D, Lin Q, Mao W. Lin F, et al. Among authors: shen d. Oncol Res. 2015;22(2):75-84. doi: 10.3727/096504014X14024160459203. Oncol Res. 2015. PMID: 25706394 Free PMC article.

10

Efficacy of adoptive cellular therapy in patients with gastric cancer: a meta-analysis.

Shen D, Liu ZH, Xu JN, Xu F, Lin QF, Lin F, Mao WD. Shen D, et al. Immunotherapy. 2016 Jul;8(8):971-81. doi: 10.2217/imt.16.10. Immunotherapy. 2016. PMID: 27381688 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,476 results

Search Page

Filters